Self-Assembled Supramolecular Nanoparticles for Targeted Delivery and Combination Chemotherapy

ChemMedChem. 2018 Oct 8;13(19):2037-2044. doi: 10.1002/cmdc.201800291. Epub 2018 Aug 21.

Abstract

It is challenging but imperative to merge imaging agents and small molecule therapeutics into one nanoentity for diagnosis and treatment. Herein, we constructed polymeric nanoparticles for targeted delivery and combination chemotherapy, which formed through host-guest interactions among three elements: 1) β-cyclodextrin polymer (poly-β-CD), as the backbone of nanoparticles; 2) two antitumor drugs-doxorubicin (DOX) and docetaxel (DTX); and 3) aptamers labeled with adamantane and fluorescein (Ad-aptamer-FAM), as recognition elements. First, polymeric nanoparticles, termed self-assembled supramolecular nanoparticles (SSNPs), were formulated by combining hydrophobic DTX and DOX with poly-β-CD via host-guest interactions. Then, the surface of SSNPs modified the aptamer to acquire targeting ability; such nanoparticles were termed targeted self-assembled supramolecular nanoparticles (T-SSNPs). As evidenced by MTS assay data, T-SSNPs exhibited significant selective cytotoxicity toward target cells. The results also indicated that combination drugs achieved a good synergistic effect with a combination index of 0.43. Thus, an effective and simple drug delivery system was constructed for targeted delivery and combination chemotherapy.

Keywords: combination chemotherapy; host-guest systems; self-assembly; synergistic effect; targeted delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Aptamers, Nucleotide / chemistry
  • Base Sequence
  • Cell Line, Tumor
  • DNA / chemistry
  • Docetaxel / pharmacology*
  • Doxorubicin / pharmacology*
  • Drug Carriers / chemistry*
  • Drug Carriers / toxicity
  • Drug Combinations
  • Drug Synergism
  • Humans
  • Nanoparticles / chemistry*
  • Nanoparticles / toxicity
  • Propylene Glycols / chemistry*
  • Propylene Glycols / toxicity
  • Theranostic Nanomedicine / methods
  • beta-Cyclodextrins / chemistry*
  • beta-Cyclodextrins / toxicity

Substances

  • Antineoplastic Agents
  • Aptamers, Nucleotide
  • Drug Carriers
  • Drug Combinations
  • Propylene Glycols
  • beta-Cyclodextrins
  • poly(beta-cyclodextrin)
  • Docetaxel
  • Doxorubicin
  • DNA